Description
Participants take on James Mitchell, CEO of Global Health Corporation, under pressure to revitalize a lagging oncology pipeline. The task: acquire BioPharma’s breakthrough treatment while retaining its talent, managing regulatory complexities, and ensuring shareholder value. This negotiation challenges students to balance aggressive market goals with ethical and operational considerations.
